Brilliant read - have been following Flow for a while now, very happy to see you do a piece on them!
I recognise this isn't the focus of the piece, but an interesting add-on on the point of trust/research; going into their history the co-founders both had academic backgrounds, and early research interests into tDCS.
I wonder if this is what led them to a key clinician-researcher champion, Andre Brunoni, a psychiatrist researcher in the tDCS space (where they published a device review in 2020).
The momentum after also seems to have come from key researchers from UEL, around the same time they obtained the FDA Breakthrough Device Designation.
In a mental health space saturated with wellness-based products, their credibility through academic collaborations shines through, and is awesome to see!
Yes I think you're bang on here Kevin. Both co-founders are super reputable which definitely helped.
Also interesting that they then brought Erin on board as CEO, coming from a business background. Seems like a good recipe for clinical and commercial success.
Brilliant read - have been following Flow for a while now, very happy to see you do a piece on them!
I recognise this isn't the focus of the piece, but an interesting add-on on the point of trust/research; going into their history the co-founders both had academic backgrounds, and early research interests into tDCS.
I wonder if this is what led them to a key clinician-researcher champion, Andre Brunoni, a psychiatrist researcher in the tDCS space (where they published a device review in 2020).
The momentum after also seems to have come from key researchers from UEL, around the same time they obtained the FDA Breakthrough Device Designation.
In a mental health space saturated with wellness-based products, their credibility through academic collaborations shines through, and is awesome to see!
Yes I think you're bang on here Kevin. Both co-founders are super reputable which definitely helped.
Also interesting that they then brought Erin on board as CEO, coming from a business background. Seems like a good recipe for clinical and commercial success.